Hoag First in World to Enroll Prostate Cancer Patients in Molecular Imaging & Therapy Clinical Trials
NEWPORT BEACH, Calif., April 2, 2024 – Hoag is the first site in the world to enroll patients in two clinical trials for prostate cancer staging and treatment. One trial focuses on molecular imaging and the other on molecular therapy; both are poised to redefine the standard of care for patients with prostate cancer worldwide. … Read More
